Clinical Trial Update: Long-term Aspirin Therapy as a Predictor of Decreased Susceptibility to SARS-CoV-2 Infection in Aspirin-Exacerbated Respiratory Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating long-term aspirin therapy as a predictor of decreased susceptibility to SARS-CoV-2 infection in aspirin-exacerbated respirator…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspirin-exacerbated Respiratory Disease

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Lucyna Mastalerz | Conditions: AERD - Aspirin Exacerbated Respiratory Disease | Phase 3 | Status: UNKNOWN